PERAMPANEL Pharmacologic Class Indexing
- Class set ID
- 25596d39-8281-4ff7-915c-1cec63e3219b
- Version
- 3
- Effective date
- 20210730
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
Label, Manufacturer, Effective table| Label | Manufacturer | Effective | SPL version |
|---|
| These highlights do not include all the information needed to use PERAMPANEL TABLETS safely and effectively. See full prescribing information for PERAMPANEL TABLETS. PERAMPANEL tablets, for oral use, CIII Initial U.S. Approval: 2012 | Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries, Ltd. | 20251219 | 4 |
| These highlights do not include all the information needed to use PERAMPANEL TABLETS safely and effectively. See full prescribing information for PERAMPANEL TABLETS. PERAMPANEL tablets, for oral use, CIII Initial U.S. Approval: 2012 | Novadoz Pharmaceuticals LLC | MSN LABORATORIES PRIVATE LIMITED | 20251126 | 1 |
| These highlights do not include all the information needed to use PERAMPANEL TABLETS safely and effectively. See full prescribing information for PERAMPANEL TABLETS. PERAMPANEL tablets, for oral use, CIII Initial U.S. Approval: 2012 | Teva Pharmaceuticals, Inc. | 20240927 | 3 |
| These highlights do not include all the information needed to use FYCOMPA ® safely and effectively. See full prescribing information for FYCOMPA ® . FYCOMPA ® (perampanel) tablets, for oral use, CIII FYCOMPA ® (perampanel) oral suspension, CIII Initial U.S. Approval: 2012 | Catalyst Pharmaceuticals, Inc. | 20240105 | 4 |
| These highlights do not include all the information needed to use FYCOMPA ® safely and effectively. See full prescribing information for FYCOMPA ® . FYCOMPA ® (perampanel) t ablets , for oral use , CIII FYCOMPA ® (perampanel) o ral s uspension , CIII Initial U.S. Approval: 20 12 | Eisai Inc. | Delpharm Huningue | Eisai Co., Ltd. | Eisai Manufacturing Ltd | F.I.S. FABBRICA ITALIANA SINTETICI S.P.A. | Pace Analytical Life Sciences, LLC | Pharma Packaging Solutions, LLC dba Tjoapack, LLC | 20221228 | 60 |
| These highlights do not include all the information needed to use PERAMPANEL ORAL SUSPENSION safely and effectively. See full prescribing information for PERAMPANEL ORAL SUSPENSION. PERAMPANEL oral suspension, CIII Initial U.S. Approval: 2012 | Novadoz Pharmaceuticals LLC | MSN Pharmaceuticals Inc. | 20221126 | 1 |